PMC8605883_01
Liver tumor on T2.
IJWH-13-1123-g0001.jpg
PMC8605883_01_IJWH-13-1123-g0001.jpg
f0001
T2-weighted (Figure 1) and decreased for T1-weighted (Figures 2 and 3). The mass had a lobe, developed along a downward pattern, and did not invade the portal vein.
Liver tumor on T1 in-phase.
IJWH-13-1123-g0002.jpg
PMC8605883_01_IJWH-13-1123-g0002.jpg
f0002
T2-weighted (Figure 1) and decreased for T1-weighted (Figures 2 and 3). The mass had a lobe, developed along a downward pattern, and did not invade the portal vein.
Liver tumor on T1 out-of -phase.
IJWH-13-1123-g0003.jpg
PMC8605883_01_IJWH-13-1123-g0003.jpg
f0003
T2-weighted (Figure 1) and decreased for T1-weighted (Figures 2 and 3). The mass had a lobe, developed along a downward pattern, and did not invade the portal vein.
Tumor histopathology.
IJWH-13-1123-g0004.jpg
PMC8605883_01_IJWH-13-1123-g0004.jpg
f0004
The remaining resected areas of the liver did not contain any more of the tumor (Figure 4).
Positive CD34. Monoclonal Mouse Anti-Human CD34 Class II Clone QBEnd 10 DK-2600 Glostrup, Denmark.
IJWH-13-1123-g0005.jpg
PMC8605883_01_IJWH-13-1123-g0005.jpg
f0005
Immunohistochemical staining showed positive CD34 (Figure 5), negative CD117, negative Dog-1, negative glypican, positive CK (Figure 6), and CD99 (Figure 7).
Immunohistochemistry CK (+). Monoclonal Mouse Anti-Human Cytokeratin Clone MNF 116 DK-2600 Glostrup, Denmark.
IJWH-13-1123-g0006.jpg
PMC8605883_01_IJWH-13-1123-g0006.jpg
f0006
Immunohistochemical staining showed positive CD34 (Figure 5), negative CD117, negative Dog-1, negative glypican, positive CK (Figure 6), and CD99 (Figure 7).
Positive CD99. Rabbit Monoclonal Primary Antibody EPR3097Y RabMAb.
IJWH-13-1123-g0007.jpg
PMC8605883_01_IJWH-13-1123-g0007.jpg
f0007
Immunohistochemical staining showed positive CD34 (Figure 5), negative CD117, negative Dog-1, negative glypican, positive CK (Figure 6), and CD99 (Figure 7).